COMPUMEDICS LIMITED (CMP)
AI Coverage Rating: Moderate
ASX AI Signals has generated 1 signal(s) for CMP during the last 90 days,
indicating Moderate trading activity
Latest CMP Signals |
| 14/05/2026 | SELL |
CMP Share Price |
| Current Price | $0.240 |
| 52 Week High | $0.450 |
| 52 Week Low: | $0.240 |
| Trading at (% of 52 Week High) | 53.33% |
Volume
61456
20 Day Avg
65845
Relative Volume
93.3%
Business Overview
Compumedics Limited (ASX: CMP) is a medical technology company that designs, manufactures, and distributes advanced diagnostic devices primarily for sleep disorders and neurodiagnostic monitoring. The company provides products and solutions used in sleep labs, hospitals, and research institutions worldwide.
ASX Sector Overview
Sector: Health Care Equipment & Services
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
Latest AI Recommendation
The SELL recommendation for COMPUMEDICS LIMITED is supported by moderate bearish signals, but the relatively low stock price and potential volatility introduce some uncertainty. Caution is advised due to market conditions and company-specific risks.
Latest COMPUMEDICS LIMITED(CMP) News
19 Mar 2026, 07:30 PM
Custom Market Insights
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Intracranial Pressure Monitoring Devices Market size & share revenue was valued at approximately USD 1.89 Billion in 2025 and is expected to reach
21 Aug 2025, 09:30 PM
Custom Market Insights
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Non-invasive Brain Trauma Monitoring Device Market size & share revenue was valued at approximately USD 14.7 Billion in 2024 and is expected to r
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial
